|
New Studies:
1. Patients who have Type II Diabetics: Insulin sensitizer medication. Please call
us at (503) 246-4022. Or email us at newhopeoforegon@aol.com.
2. Patients with Chronic Low Back Pain: Pain/Anti-inflammatory medication.
Please call us at (503) 246-4022. Or email us at newhopeoforegon@aol.com.
3. Patients with Migraine Headaches: New rapid absorption preparation of proven migraine
medication. Please call us at (503) 246-4022. Or email us at newhopeoforegon@aol.com.
4. Patients with Leg Pain from Claudication (poor circulation): Please call us at (503)
246-4022. Or email us at newhopeoforegon@aol.com.
5. Patients interested in Abdominal Pain and/or bloating: Please call us at (503) 246-4022.
Or email us at newhopeoforegon@aol.com.
Ongoing Studies:
1. A 6-week, Open Label, Dose - comparison Study to evaluate the Safety and Efficacy of Rosuvastatin
verses Atorvastatin, Pravastatin, and Simvastatin in Subjects with Hypercholesterolemia. 12/2001 - 03/2002.
2.
A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Carvedilol and Metoprolol
in Hypertensive Patients with Type II Diabetes Mellitis, 05/2001 - Current.
3. Protocol 21-98-214-01: Randomized,
Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm, Study to Assess the Long-Term Effects of Pletal (cilostazol)
verses Placebo Administered Orally to Patients with Intermittent Claudication Secondary to Periferal Arterial Disease, 10/2001
- Current.
4. A 24-Week Randomized, Double-Blind, Multicenter, Study to Compare the Efficacy of Avandia when
added to Submaximal Doses of Metformin and to Compare the Tolerability of the Combination to Metformin Monotherapy when Administered
to Patients with Type II Diabetes, 12/2001 - 05/2002.
5. An Open-Label, Randomized, Multicenter, Phase IIIb,
Parallel Group, Switching Study to Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin with
Rosuvastatin in High-Risk Subjects with Type IIa and IIb Hypercholesterolemia, 01/2002 - Current.
6. Double-Blind,
Randomized, Dose-Ranging, Parallel-Group Comparison of the Efficacy and Safety of the Extended Release Tramadol Hydrochloride
(Tramadol HC1 ER) 100mg, 200mg, and 300mg, Celecoxib 200mg and Placebo in the Treatment of Osteoarthritis of the Knee and/or
the Hip, 08/2002 - Current.
7. A Double-Blind, Randomized, Active and Placebo Controlled, Multicenter, Dose-Ranging
Evaluation of (S)-Amlodipine in Hypertensive Subjects, 08/2002 - Current.
|
